The consequences of delayed diagnosis and treatment in persons with multiple sclerosis given autologous hematopoietic stem cell transplantation.

María de Lourdes Pastelín-MartínezMoisés Manuel Gallardo-PérezAndrés Gómez-de-LeónJuan Carlos Olivares-GazcaEdgar Jared Hernández-FloresDaniela Sánchez-BonillaMerittzel Montes-RoblesMax Robles-NastaGuillermo Ocaña-RammSilvia Soto-OlveraDavid Gómez-AlmaguerGuillermo J Ruiz-DelgadoGuillermo José Ruiz-Arguelles

Published in: Diagnosis (Berlin, Germany) (2024)

These data indicate that both the pre-transplant progression of the disease and the response to aHSCT were significantly worse in the DD group. An early diagnosis and an early aHSCT intervention are critical for a good prognosis, in terms of lowering and stabilizing the motor disability in MS patients given autografts.

Keyphrases

multiple sclerosis
end stage renal disease
ejection fraction
newly diagnosed
randomized controlled trial
acute myeloid leukemia
mass spectrometry
peritoneal dialysis
prognostic factors
white matter
electronic health record
ms ms
stem cells
machine learning
patient reported
data analysis